MMP-9 Level Comparation between Spontaneous Abortion and Normal Pregnancy
Abstract
BACKGROUND: Abortion remains a problem in the obstetric care as it is one of the causes of maternal and fetal death. Bleeding or miscarriage threat in the first trimester comprises 20% to 25% of all pregnant women, and 50% of them will end as spontaneous abortion. The major cause of maternal death in abortion is hemorrhage. Some recent studies have indicated that MMP-9 is important in the process of embryo implantation into the endometrium and spontaneous abortion occurs when there is an overwhelming increase of MMP-9. This data indicate the importance of a further research to elucidate the role of MMP-9 in spontaneous abortion.
METHODS: This was a cross sectional study, included 70 pregnant women with gestational age <20 weeks who came for examination and treatment at the Department of Obstetrics and Gynecology, Medical Faculty of Padjadjaran University/Hasan Sadikin Hospital, Bandung.
RESULTS: There were differences in the MMP-9 levels in spontaneous abortion compared to normal pregnancy and MMP-9 had a cut-off point >1221.7 with the sensitivity of 48.6% specificity of 80%, and accuracy of 60.9%.
SUMMARY: The MMP-9 level in spontaneous abortion was higher than in normal pregnancy.
KEYWORDS: MMP-9, spontaneous abortion, normal pregnancy
Full Text:
PDFReferences
Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Gilstrap III LC, Wenstrom KD. Abortion. In: Cunningham FG, Williams JW, editors. Williams obstetrics. 22 ed. New York: McGraw Hill; 2005. p. 231-51, NLMID.
Christiansen OB. Epidemiology of recurrent pregnancy loss. In: Carp HJA, editor. Recurrent pregnancy loss causes, controversies and treatment. 1 ed. London: Informa Healthcare; 2007. p. 1-13, NLMID.
Luisi S, Lazzeri L, Genazzani AR. Endocrinology of pregnancy loss. In: Carp HJA, editor. Recurrent Pregnancy loss causes, controversies and treatment. London: Informa Healthcare; 2007. p. 79-87, NLMID.
Barnea ER. Insight into early pregnancy: emerging role of the embryo. Am J Reprod Immunol. 2004; 51: 319-22, CrossRef.
Rosevear S. Bleeding in early pregnancy. In: James DK SJ, Weiner CP, Gonik B, editors. High Risk Pregnancy Management Options. 2nd ed. London: WB. Saunders; 2000. p. 61-89.
Zhao FX, Zhang YY, Liu RH, Li SM. Effect of blockage of co-stimulatory signal on murine abortion-prone model. Chinese Medical Journal. 2007; 120: 1247-50, PMID.
Zhao JX, Lin ZM , Yao HW, Wan YL. Analysis of the relationship between expressions of TF and MMP-9 and prognosis of breast cancer. Chinese Journal of Clinical Oncology. 2008; 5: 1141-5, CrossRef.
McCawley LJ, Matrisian LM. Matrix metalloproteinases: They're not just for matrix anymore! Curr Opin Cell Biol. 2001; 13: 534-40, CrossRef.
Strakova Z, Szmidt M, Srisuparp S, Fazleabas AT. Inhibition of matrix metalloproteinases prevents the synthesis of insulin-like growth factor binding protein-1 during decidualization in the baboon. Endocrinology. 2003; 144: 5339-46, CrossRef.
Staun-Ram E, Goldman S, Gabarin D, Shalev E. Expression and importance of matrix metalloproteinase 2 and 9 (MMP-2 and MMP-9) in human trophoblast invasion. Reprod Biol Endocrinol. 2004; 2: 59, PMID.
Lim KJH, Olusegun A, Ajjan RA, Li TC, Weetman AP, Cook ID. The role of T helper cytokines in human reproduction. Fertil Steril. 2000; 73: 136-42, CrossRef.
Seval Y, Akkoyunlu G, Demir R, Asar M. Distribution patterns of matrix metalloproteinase (MMP)-2 and -9 and their inhibitors (TIMP-1 and TIMP-2) in the human decidua during early pregnancy. Acta Histochem. 2004; 106: 353-62, CrossRef.
Yu YH, Wang ZJ. Relationship between matrix metalloproteinase-9 expression in syncytiotrophoblast and placenta pathologic change of intrauterine growth restriction. Chin J Perinat Med. 2003; 4: 215-7, article.
DOI: https://doi.org/10.18585/inabj.v4i3.178
Copyright (c) 2012 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
